Offer - Urjas Oil for just ₹ 1 X
Dapaglyn M Tablet is an allopathic medicine The correct dosage of Dapaglyn M Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Dapaglyn M Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Dapaglyn M Tablet safe for pregnant women?
Dapaglyn M Tablet has many dangerous side effects in pregnant women. If you are pregnant, do not consume Dapaglyn M Tablet without medical advice.
Is the use of Dapaglyn M Tablet safe during breastfeeding?
There is no research available on the side effects of Dapaglyn M Tablet in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Dapaglyn M Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Dapaglyn M Tablet. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Dapaglyn M Tablet on the Liver?
The liver can be affected by Dapaglyn M Tablet. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Dapaglyn M Tablet only after medical advice.
What is the effect of Dapaglyn M Tablet on the Heart?
Information about safety of Dapaglyn M Tablet for heart is not available since scientific research on this is yet to be done.
Dapaglyn M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dapaglyn M Tablet unless your doctor advises you to do so -
Is this Dapaglyn M Tablet habit forming or addictive?
Forming a habit of Dapaglyn M Tablet has not been reported.
Interaction between Food and Dapaglyn M Tablet
There is no information on the effects of taking Dapaglyn M Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Dapaglyn M Tablet
Consuming Dapaglyn M Tablet with alcohol can have many serious effects on your body.
Yes, Dapaglyn M Tablet can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Dapaglyn M Tablet causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Dapaglyn M Tablet may need to be adjusted.
Dapaglyn M Tablet works by decreasing the hepatic glucose production. It also works to lower blood sugar by increasing your sensitivity to insulin and decreasing the amount of glucose that is absorbed from the food you eat.
Yes, Dapaglyn M Tablet can cause some sleep problems, especially insomnia. On the other hand, Dapaglyn M Tablet has proven to be useful for preventing sleep apnea. The exact relationship between Dapaglyn M Tablet and sleep problems is still not clear, and further studies are needed for a clearer understanding.
No, you should not take alcohol with Dapaglyn M Tablet, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Dapaglyn M Tablet than if you're just taking Dapaglyn M Tablet. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
Dapaglyn M Tablet can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278